SCHEMBL11643448

SCHEMBL11643448

Clc1cc2cnccc2s1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2A6 P11509 8/20 0.55
CYP17A1 P05093 1/20 0.40
TGFBR1 P36897 8/20 0.38
IMPDH2 P12268 1/20 0.36
CHEK1 O14757 1/20 0.36
AURKA O14965 1/20 0.36
DAPK3 O43293 1/20 0.36
PRKD3 O94806 1/20 0.36
MAP4K4 O95819 1/20 0.36
PAK4 O96013 1/20 0.36
ABL1 P00519 1/20 0.36
RET P07949 1/20 0.36
PIM1 P11309 1/20 0.36
FGFR1 P11362 1/20 0.36
PRKACA P17612 1/20 0.36
FLT1 P17948 1/20 0.36
LTK P29376 1/20 0.36
GRK5 P34947 1/20 0.36
KDR P35968 1/20 0.36
MAPK8 P45983 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11071527 0.77 CYP2A6 (0.56) CYP2A6TGFBR1CHEK1AURKADAPK3
SCHEMBL10677527 0.75 CYP2A6 (0.55) CYP2A6TGFBR1CHEK1AURKADAPK3
SCHEMBL7113297 0.75 CYP2A6 (0.55) CYP2A6TGFBR1IMPDH2CHEK1AURKA
SCHEMBL16023619 0.75 CYP2A6 (0.55) CYP2A6TGFBR1CHEK1AURKADAPK3
SCHEMBL11070896 0.75 CYP2A6 (0.65) CYP2A6TGFBR1IMPDH2CHEK1AURKA
SCHEMBL3483101 0.75 CYP2A6 (0.55) CYP2A6TGFBR1CHEK1AURKADAPK3
SCHEMBL8467739 0.73 CYP2A6 (0.53) CYP2A6TGFBR1CHEK1AURKADAPK3
Hydrochloric Acid SCHEMBL27139693 0.73 CYP2A6 (0.62) CYP2A6TGFBR1IMPDH2CHEK1AURKA
SCHEMBL31227630 0.72 CYP2A6 (0.51) CYP2A6TGFBR1TGFB2
SCHEMBL12689590 0.72 CYP2A6 (0.51) CYP2A6TGFBR1CHEK1AURKADAPK3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240018125-A1 CYCLIC ISOTHIOUREA DERIVATIVES AS CXCR4 MODULATORS ERMIUM THERAPEUTICS (FR) 2024-01-18 US disclosed
US-4075215-A ANTIARRHYTHMIA AGENTS CENTRE D'ETUDES POUR L'INDUSTRIE PHARMACEUTIQUE (FR) 1978-02-21 US disclosed
US-4051141-A ANTIINFLAMMATORY, VASODILATOR, ANTICOAGULANTS CENTRE D'ETUDES POUR L'INDUSTRIE PHARMACEUTIQUE (FR) 1977-09-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240018125-A1 CYCLIC ISOTHIOUREA DERIVATIVES AS CXCR4 MODULATORS CXCR4, CXCR1, CXCL12 CYP2A6 4263/4885CYP17A1 3728/4885TGFBR1 972/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.